|
| Press Releases |
|
 |
|
| Tuesday, September 3, 2024 |
|
|
The 18th Frost & Sullivan Growth, Innovation and Leadership Summit, China: A Huge Success |
| The 18th Frost & Sullivan Growth, Innovation and Leadership Summit and the 3rd New Investment Event (NIE 2024), was held in Shanghai from August 27-30, 2024, co-hosted by LeadLeo. more info >> |
|
|
2024沙利文新投資大會圓滿閉幕：凝新聚力，質贏未來 |
| 由弗若斯特沙利文（Frost & Sullivan，簡稱：“沙利文”）主辦，頭豹協辦的2024第十八届沙利文中國增長、科創與領導力峰會暨第三届新投資大會於8月28日-8月30日在上海靜安瑞吉酒店成功舉辦。 more info >> |
|
|
2024沙利文新投资大会圆满闭幕：凝新聚力，质赢未来 |
| 由弗若斯特沙利文（Frost & Sullivan，简称：“沙利文”）主办，头豹协办的2024第十八届沙利文中国增长、科创与领导力峰会暨第三届新投资大会于8月28日-8月30日在上海静安瑞吉酒店成功举办。 more info >> |
|
| Wednesday, July 8, 2020 |
|
|
Frost & Sullivan Honors Leading Organizations in Asia-Pacific in an Inaugural Virtual Ceremony for the 2020 Asia-Pacific Best Practices Awards |
| Frost & Sullivan honored Asia-Pacific's leading companies at the 18th annual Asia-Pacific Best Practices Awards on 8 July in an inaugural virtual awards ceremony. more info >> |
|
| Friday, March 3, 2017 |
|
|
Frost＆Sullivan的最新研究顯示亞洲是臨床試驗的首選地 |
Frost＆Sullivan今天發布了其與亞太專家CRO Novotech合作的最新白皮書“亞洲：臨床試驗的首選地”。新白皮書的研究表明，由於擁有大量無治療效果的患者庫，特殊的臨床基礎設施和人才，以及較低的運營成本，亞洲正迅速成為臨床研究的主力軍。
more info >> |
|
|
Frost＆Sullivan的最新研究显示亚洲是临床试验的首选地 |
Frost＆Sullivan今天发布了其与亚太专家CRO Novotech合作的最新白皮书“亚洲：临床试验的首选地”。新白皮书的研究表明，由于拥有大量无治疗效果的患者库，特殊的临床基础设施和人才，以及较低的运营成本，亚洲正迅速成为临床研究的主力军。
more info >> |
|
|
New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials |
| Frost & Sullivan released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific specialist CRO Novotech. Research from the new white paper revealed Asia is quickly becoming a clinical research powerhouse. more info >> |
|
| Wednesday, June 25, 2014 |
|
|
Fast-Evolving US Cardiac Ablation Industry Affords Multiplying Niche Opportunities, Says Frost & Sullivan |
| Recent analysis from Frost & Sullivan's Analysis of the US Cardiac Ablation Market finds the market earned revenue of $2.77 billion in 2013 and estimates this to reach $5.75 billion in 2020. The analysis covers catheter ablation, surgical ablation and cardiac mapping. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
XCF Global and Continual Renewable Ventures Announce Memorandum of Understanding to Launch New Rise Australia, a SAF and HVO Platform Powered by XCF
Jun 26, 2025 09:30 HKT/SGT
|
|
|
穩定幣條例下的隱形巨頭：百仕達的真實價值
Jun 26, 2025 09:03 HKT/SGT
|
|
|
稳定币条例下的隐形巨头：百仕达的真实价值
Jun 26, 2025 08:59 HKT/SGT
|
|
|
港股「香水第一股」穎通控股（06883）今日正式掛牌
Jun 26, 2025 07:05 HKT/SGT
|
|
|
港股“香水第一股”颖通控股（06883）今日正式挂牌
Jun 26, 2025 07:02 HKT/SGT
|
|
|
Investing News Network Strengthens Australian Presence with Appointment of Industry Veteran John Phillips
Jun 26, 2025 00:39 HKT/SGT
|
|
|
Silo Pharma Enters into Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Jun 25, 2025 22:27: JST
|
|
|
交易寶2025年5月亮相HOFEX 2025及HK Tech 300 Expo 助力商戶數碼轉型
Jun 25, 2025 22:21 HKT/SGT
|
|
|
PCG Showcases at HOFEX 2025 and HK Tech 300 Expo in May 2025, Driving Digital Transformation for Merchants
Jun 25, 2025 22:17 HKT/SGT
|
|
|
Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Jun 25, 2025 22:27 JST
|
|
|
Galaxy Payroll Partners with CURRENC to Integrate AI and Stablecoin Technology in HR Solutions
Jun 25, 2025 20:30 HKT/SGT
|
|
|
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange
Jun 25, 2025 19:00: JST
|
|
|
康哲藥業建議於新加坡交易所第二上市
Jun 25, 2025 18:13 HKT/SGT
|
|
|
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange
Jun 25, 2025 18:00 HKT/SGT
|
|
|
從技術先驅到全球AMR第一 極智嘉商業化領跑行業
Jun 25, 2025 17:45 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
